Previous studies suggested that serum osteocalcin concentrations are positively associated with markers of insulin sensitivity and negatively associated with fasting blood glucose (FBG), insulin resistance, body mass index (BMI), fat mass, and MetS [9, 10]. Here, BGLAP is linked to metabolic syndrome.